Literature DB >> 15951120

Basic fibroblast growth factor stimulates functional recovery after neonatal lesions of motor cortex in rats.

M-H Monfils1, I Driscoll, P M Vandenberg, N J Thomas, D Danka, J A Kleim, B Kolb.   

Abstract

Rats were given bilateral lesions of the motor cortex on the tenth day of life, and then received a daily subcutaneously injection of either basic fibroblast growth factor (FGF-2) or vehicle for 7 consecutive days. In adulthood, they were trained and assessed on a skilled forelimb reaching task. Although all lesion groups were impaired at skilled reaching, the postnatal day 10-lesioned group that received FGF-2 was less impaired than the lesion group that received the vehicle. Furthermore, the lesioned rats that received FGF-2 showed a filling of the lesion cavity with tissue, whereas the lesioned vehicle-treated rats still had a prominent lesion cavity. The functionality of the tissue filling the cavity, tissue surrounding it, and tissue from the motor cortex (in control rats) was assessed using intracortical microstimulation, and showed that stimulation of some sites from the filled cavity could evoke movement. The rats were perfused and processed for Golgi-Cox staining. Medium spiny neurons from the striatum were drawn and analyzed, and the results suggest that postnatal day 10 lesions of the motor cortex induced an increase in the length and complexity of these cells compared with those of non-lesioned rats. Our results suggest that FGF-2 may play an important role in recovery from early brain damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951120     DOI: 10.1016/j.neuroscience.2005.04.006

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

Review 1.  Sensitive Periods for Recovery from Early Brain Injury.

Authors:  Bryan Kolb
Journal:  Curr Top Behav Neurosci       Date:  2022

2.  Developmental mercury exposure elicits acute hippocampal cell death, reductions in neurogenesis, and severe learning deficits during puberty.

Authors:  Anthony Falluel-Morel; Katie Sokolowski; Helene M Sisti; Xiaofeng Zhou; Tracey J Shors; Emanuel Dicicco-Bloom
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

Review 3.  Hitting a moving target: Basic mechanisms of recovery from acquired developmental brain injury.

Authors:  Christopher C Giza; Bryan Kolb; Neil G Harris; Robert F Asarnow; Mayumi L Prins
Journal:  Dev Neurorehabil       Date:  2009       Impact factor: 2.308

4.  Factors influencing cerebral plasticity in the normal and injured brain.

Authors:  Bryan Kolb; G Campbell Teskey; Robbin Gibb
Journal:  Front Hum Neurosci       Date:  2010-11-02       Impact factor: 3.169

5.  FGF-2-induced functional improvement from neonatal motor cortex injury via corticospinal projections.

Authors:  Marie H Monfils; Ira Driscoll; Romana Vavrek; Bryan Kolb; Karim Fouad
Journal:  Exp Brain Res       Date:  2007-10-26       Impact factor: 1.972

6.  Developmental and interventional plasticity of motor maps after perinatal stroke.

Authors:  Sarah Y Zhang; Matthew S Jeffers; Diane C Lagace; Adam Kirton; Gergely Silasi
Journal:  J Neurosci       Date:  2021-06-01       Impact factor: 6.167

Review 7.  Fibroblast growth factors in the management of spinal cord injury.

Authors:  Yulong Zhou; Zhouguang Wang; Jiawei Li; Xiaokun Li; Jian Xiao
Journal:  J Cell Mol Med       Date:  2017-10-24       Impact factor: 5.310

8.  Ghrelin Ameliorates Traumatic Brain Injury by Down-Regulating bFGF and FGF-BP.

Authors:  Xuefei Shao; Qianxin Hu; Sansong Chen; Qifu Wang; Pengcheng Xu; Xiaochun Jiang
Journal:  Front Neurosci       Date:  2018-07-05       Impact factor: 4.677

9.  Exposure to organophosphates reduces the expression of neurotrophic factors in neonatal rat brain regions: similarities and differences in the effects of chlorpyrifos and diazinon on the fibroblast growth factor superfamily.

Authors:  Theodore A Slotkin; Frederic J Seidler; Fabio Fumagalli
Journal:  Environ Health Perspect       Date:  2007-02-27       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.